Clinical and Molecular Biomarker Studies in RAI1 (Retinoic Acid-Induced 1) -Related Disorders

RecruitingOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

March 13, 2024

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
RAI1 Gene 17P11.2 Deletion+Duplication
Interventions
DIAGNOSTIC_TEST

Electroencephalography/Polysomnography (EEG/PSG)

Instigators will determine if subjects are candidate for the procedure. A sleep study records the brain electrical waves, the oxygen level in the blood, heart rate breathing, as well as eye and leg movements. Subjects will need to be admitted overnight for the sleep study.

PROCEDURE

Skin Biopsy

A special 3-4 mm (0.12 inches) wide circular tool will be used to remove a small section of skin including deeper layers. A numbing cream or injectable anesthetic (i.e. lidocaine) will be applied to the area before the procedure. Sample will be used to create a cell line. This means that investigators would treat the cells from the sample in a way that allows to grow them in the laboratory. Investigators will then use these cells in research.

DIAGNOSTIC_TEST

Blood draw

A single blood sample of 15 cc (not exceeding 3 cc per kg) (\~3 teaspoons) will be collected for metabolomics (biomarker) study. From available family members, same amount of blood will be obtained to use as a control sample.

Trial Locations (1)

77030

RECRUITING

Texas Children's Hospital, Houston

All Listed Sponsors
collaborator

Doris Duke Charitable Foundation

OTHER

lead

Baylor College of Medicine

OTHER